Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cidara Therapeutics (CDTX) Change in Acquisitions & Divestments: 2015-2018

Historic Change in Acquisitions & Divestments for Cidara Therapeutics (CDTX) over the last 4 years, with Dec 2018 value amounting to $29.0 million.

  • Cidara Therapeutics' Change in Acquisitions & Divestments fell 10.00% to $4.5 million in Q4 2018 from the same period last year, while for Dec 2018 it was $29.0 million, marking a year-over-year change of. This contributed to the annual value of $29.0 million for FY2018, which is 19.45% up from last year.
  • Latest data reveals that Cidara Therapeutics reported Change in Acquisitions & Divestments of $29.0 million as of FY2018, which was up 19.45% from $24.3 million recorded in FY2017.
  • Over the past 5 years, Cidara Therapeutics' Change in Acquisitions & Divestments peaked at $95.5 million during FY2016, and registered a low of $10.0 million during FY2015.
  • Over the past 3 years, Cidara Therapeutics' median Change in Acquisitions & Divestments value was $29.0 million (recorded in 2018), while the average stood at $49.6 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first spiked by 855.00% in 2016, then slumped by 74.55% in 2017.
  • Yearly analysis of 4 years shows Cidara Therapeutics' Change in Acquisitions & Divestments stood at $10.0 million in 2015, then spiked by 855.00% to $95.5 million in 2016, then crashed by 74.55% to $24.3 million in 2017, then rose by 19.45% to $29.0 million in 2018.